| 000 | 01768 a2200505 4500 | ||
|---|---|---|---|
| 005 | 20250517021842.0 | ||
| 264 | 0 | _c20151201 | |
| 008 | 201512s 0 0 eng d | ||
| 022 | _a2314-7156 | ||
| 024 | 7 |
_a10.1155/2015/743828 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aZhong, Boya | |
| 245 | 0 | 0 |
_aFas ligand DNA enhances a vaccination effect by coadministered DNA encoding a tumor antigen through augmenting production of antibody against the tumor antigen. _h[electronic resource] |
| 260 |
_bJournal of immunology research _c2015 |
||
| 300 |
_a743828 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntibodies _ximmunology |
| 650 | 0 | 4 |
_aAntibody Formation _ximmunology |
| 650 | 0 | 4 |
_aAntigens, Neoplasm _xadministration & dosage |
| 650 | 0 | 4 |
_aCancer Vaccines _xgenetics |
| 650 | 0 | 4 | _aCell Line, Tumor |
| 650 | 0 | 4 | _aDisease Models, Animal |
| 650 | 0 | 4 |
_aFas Ligand Protein _xgenetics |
| 650 | 0 | 4 | _aImmunization |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 |
_aNeoplasms _ximmunology |
| 650 | 0 | 4 |
_aT-Cell Antigen Receptor Specificity _ximmunology |
| 650 | 0 | 4 |
_aT-Lymphocytes _ximmunology |
| 650 | 0 | 4 | _aTransgenes |
| 650 | 0 | 4 |
_aVaccines, DNA _xadministration & dosage |
| 700 | 1 | _aMa, Guangyu | |
| 700 | 1 | _aSato, Ayako | |
| 700 | 1 | _aShimozato, Osamu | |
| 700 | 1 | _aLiu, Hongdan | |
| 700 | 1 | _aLi, Quanhai | |
| 700 | 1 | _aShingyoji, Masato | |
| 700 | 1 | _aTada, Yuji | |
| 700 | 1 | _aTatsumi, Koichiro | |
| 700 | 1 | _aShimada, Hideaki | |
| 700 | 1 | _aHiroshima, Kenzo | |
| 700 | 1 | _aTagawa, Masatoshi | |
| 773 | 0 |
_tJournal of immunology research _gvol. 2015 _gp. 743828 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1155/2015/743828 _zAvailable from publisher's website |
| 999 |
_c24697053 _d24697053 |
||